Diabetes Death Rate by Race and Sex in the U.S., 1979-2006TriMark PublicationsDecember 15, 2008 SKU: TRI2047477 |
|
Croatia in 2030: The Future Demographic
5/9/2012 | published by: Euromonitor International
Croatia is experiencing depopulation which will continue over the next 20 years. The population is ageing steadily and life expectancy is rising. Fertility rate and birth rate are low, leading to natural depopulation. Emigration from
|
more...
|
$900.00
|
|
Israel in 2030: The Future Demographic
5/9/2012 | published by: Euromonitor International
In 2030, the population of Israel will reach 10.1 million, an increase of 32.9% from 2010. Females outlive males and the gap will increase over time. The Israeli immigrant population is highly educated, and includes
|
more...
|
$900.00
|
|
Freedonia Focus on Diabetes Monitoring Products: United States
5/31/2012 | published by: Freedonia Focus
This report discusses US demand for diabetes monitoring products for the years 2006 and 2011, with forecasts for 2016. Topics covered include market size, product and market segmentation, regulatory considerations, product development, market environment, product
|
more...
|
$600.00
|
|
Targeted Health and Wellness Foods and Beverages: The U.S. Market and Global Trends
3/1/2012 | published by: Packaged Facts
The market for targeted health and wellness foods and beverages is a dynamic and promising one, driven largely by the growing recognition—among scientists, government, practitioners, and consumers alike—of the instrumental role diet plays in a
|
more...
|
$3,500.00
|
|
Ukraine in 2030: The Future Demographic
4/18/2012 | published by: Euromonitor International
In 2030, the population of Ukraine will reach 42.6 million, a decrease of 7.0% from 2010. Total population in Ukraine has been falling since the mid 1990s. Much of the immigration to Ukraine is actually
|
more...
|
$900.00
|
|
Diabetic Retinopathy Global Clinical Trials Review, H1, 2012
4/25/2012 | published by: GlobalData
Diabetic Retinopathy Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Diabetic Retinopathy Global Clinical Trials Review, H1, 2012 provides data on the Diabetic Retinopathy clinical trial scenario. This report provides elemental information and data
|
more...
|
$1,000.00
|
|
Singapore in 2030: The Future Demographic
4/5/2012 | published by: Euromonitor International
In 2030, the population of Singapore will reach 6.0 million, an increase of 17.5% from 2010. Singapore is an attractive destination for immigrants and net migration has been positive since the mid nineties, except during
|
more...
|
$900.00
|
|
South African Segment Report: Emerging Market (LSM 7)
3/29/2012 | published by: Analytix Business Intelligence
This 85 page PowerPoint report examines the LSM 7 segment of South Africa and provides a comprehensive profile of the LSM 7 segment (emerging market). In 2011, 11.0% of all South African adults lived in
|
more...
|
$950.00
|
|
South African Segment Report: Mass Market - LSM 6
3/30/2012 | published by: Analytix Business Intelligence
This 91 page PowerPoint report examines the LSM 6 segment of South Africa and provides a comprehensive profile of the LSM 6 segment (mass market). In 2011, 21% of all South African adults lived in
|
more...
|
$950.00
|
|
Type 2 Diabetes - Global Drug Forecasts and Treatment Analysis to 2020
2/29/2012 | published by: GlobalData
Type 2 Diabetes - Global Drug Forecasts and Treatment Analysis to 2020 Summary GlobalData, the industry analysis specialist, has released its new report, “Type 2 Diabetes - Global Drug Forecasts and Treatment Analysis to 2020”. The report
|
more...
|
$6,995.00
|
